Posted inClinical Updates Respiratory
Dupilumab Enhances Lung Function in COPD Patients with Type 2 Inflammation: Insights from BOREAS and NOTUS Trials
Dupilumab significantly improves lung function parameters in COPD patients with type 2 inflammation, demonstrating sustained benefits regardless of smoking status or emphysema presence.





